Trial intelligence / Profile preview

Clopirin vs Clopidogrel and Aspirin in Korean Post-PCI Patients

NCT02410083Phase 4Completed

Sponsor
Jeil Pharmaceutical Co., Ltd.
Start
Nov 2012
Primary completion
Apr 2013
Modality
Small Molecules
01

Overview

A Phase 4 trial of clopidogrel in coronary artery disease (CAD), sponsored by Jeil Pharmaceutical Co., Ltd.. Started Nov 2012; status: completed.

02

Drugs

clopidogrel
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT02410083.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02410083.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call